Donor-derived acute myeloid leukemia in solid organ transplantation.

basic (laboratory) research science complication: malignant donors and donation genetics genomics hematology/oncology solid organ transplantation translational research/science

Journal

American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons
ISSN: 1600-6143
Titre abrégé: Am J Transplant
Pays: United States
ID NLM: 100968638

Informations de publication

Date de publication:
12 2022
Historique:
revised: 03 08 2022
received: 13 01 2022
accepted: 12 08 2022
pubmed: 19 8 2022
medline: 6 12 2022
entrez: 18 8 2022
Statut: ppublish

Résumé

We report the transmission of acute myeloid leukemia (AML) undetected at donation from a deceased organ donor to two kidneys and one liver recipients. We reviewed the medical records, and performed molecular analyses and whole exome sequencing (WES) to ascertain AML donor origin and its molecular evolution. The liver recipient was diagnosed 11 months after transplantation and died from complications 2 months later. The two kidney recipients (R1 and R2) were diagnosed 19 and 20 months after transplantation and both received treatment for leukemia. R1 died of complications 11 months after diagnosis, while R2 went into complete remission for 44 months, before relapsing. R2 died 10 months later of complications from allogenic bone marrow transplantation. Microsatellite analysis demonstrated donor chimerism in circulating cells from both kidney recipients. Targeted molecular analyses and medical records revealed NPM1 mutation present in the donor and recipients, while FLT3 was mutated only in R1. These findings were confirmed by WES, which revealed additional founder and clonal mutations, and HLA genomic loss in R2. In conclusion, we report the first in-depth genomic analysis of AML transmission following solid organ transplantation, revealing distinct clonal evolution, and providing a potential molecular explanation for tumor escape.

Identifiants

pubmed: 35979657
doi: 10.1111/ajt.17174
pii: S1600-6135(23)00063-1
pmc: PMC9897593
mid: NIHMS1837110
doi:

Substances chimiques

Nuclear Proteins 0
Nucleophosmin 117896-08-9

Types de publication

Journal Article Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

3111-3119

Subventions

Organisme : NCI NIH HHS
ID : R01 CA200859
Pays : United States

Commentaires et corrections

Type : CommentIn

Informations de copyright

© 2022 The American Society of Transplantation and the American Society of Transplant Surgeons.

Références

Leukemia. 2016 Sep;30(9):1916-1920
pubmed: 26975880
N Engl J Med. 1993 Mar 18;328(11):762-5
pubmed: 8094887
N Engl J Med. 2009 Jul 30;361(5):478-88
pubmed: 19641204
Nat Med. 2002 Jul;8(7):743-50
pubmed: 12091906
Am J Transplant. 2018 Jul;18(7):1810-1814
pubmed: 29633548
Int J Clin Exp Pathol. 2015 Oct 01;8(10):13655-60
pubmed: 26722593
Br J Haematol. 2014 Jul;166(2):209-12
pubmed: 24661075
PLoS Comput Biol. 2016 Apr 21;12(4):e1004873
pubmed: 27100738
Nat Genet. 2011 May;43(5):491-8
pubmed: 21478889
N Engl J Med. 2008 May 1;358(18):1909-18
pubmed: 18450602
N Engl J Med. 1999 Sep 9;341(11):807-13
pubmed: 10477779
Transplantation. 2012 Dec 27;94(12):1200-7
pubmed: 23269448
N Engl J Med. 2014 Dec 25;371(26):2488-98
pubmed: 25426837
Nature. 2018 Jul;559(7714):400-404
pubmed: 29988082
Nat Med. 2018 Jul;24(7):1015-1023
pubmed: 29988143
Br J Surg. 2014 Jun;101(7):768-74
pubmed: 24771410
N Engl J Med. 2014 Dec 25;371(26):2477-87
pubmed: 25426838
Eur J Haematol. 2014 Jun;92(6):459-66
pubmed: 24527695
Transplantation. 2002 Aug 15;74(3):358-62
pubmed: 12177614
Blood. 2013 Jul 11;122(2):298-300
pubmed: 23847191
Genome Biol. 2016 Jun 06;17(1):122
pubmed: 27268795
Genome Res. 2010 Sep;20(9):1297-303
pubmed: 20644199
Fly (Austin). 2012 Apr-Jun;6(2):80-92
pubmed: 22728672
Am J Transplant. 2011 Jun;11(6):1123-30
pubmed: 21443676
Bioinformatics. 2009 Nov 1;25(21):2865-71
pubmed: 19561018
Blood. 2020 Oct 8;136(15):1707-1721
pubmed: 32609823
J Cancer. 2021 Jan 1;12(1):28-37
pubmed: 33391400
Curr Opin Hematol. 2020 Mar;27(2):49-57
pubmed: 31972687

Auteurs

Luigi Marchionni (L)

Department of Pathology and Laboratory Medicine, Weill Cornell Medicine, New York, New York, USA.
Department of Oncology, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.

Francisco Pereira Lobo (FP)

Department of Genetics, Ecology and Evolution, Federal University of Minas Gerais, Belo Horizonte, Brazil.

Rumen Kostadinov (R)

Department of Oncology, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.

Anna Serra (A)

Department of Clinical and Biological Sciences, University of Turin, Torino, Italy.

Federico Genzano Besso (FG)

Immunogenetics and Transplant Biology Service, Azienda Ospedaliero-Universitaria Città della Salute e della Scienza, Torino, Italy.

Silvia Deaglio (S)

Immunogenetics and Transplant Biology Service, Azienda Ospedaliero-Universitaria Città della Salute e della Scienza, Torino, Italy.
Department of Medical Sciences, University of Turin, Torino, Italy.

Piero Stratta (P)

Department of Clinical and Experimental Medicine, University of Eastern Piedmont, Novara, Italy.

Monica Berrino (M)

Immunogenetics and Transplant Biology Service, Azienda Ospedaliero-Universitaria Città della Salute e della Scienza, Torino, Italy.

Claudio Zanettini (C)

Department of Pathology and Laboratory Medicine, Weill Cornell Medicine, New York, New York, USA.

Eddie Luidy Imada (EL)

Department of Pathology and Laboratory Medicine, Weill Cornell Medicine, New York, New York, USA.

Mohamed N Omar (MN)

Department of Pathology and Laboratory Medicine, Weill Cornell Medicine, New York, New York, USA.

Gianluca Gaidano (G)

Department of Translational Medicine, University of Eastern Piedmont, Novara, Italy.

Benedetto Bruno (B)

Department of Molecular Biotechnology and Health Sciences, University of Turin, Torino, Italy.

Giuseppe Saglio (G)

Department of Clinical and Biological Sciences, University of Turin, Torino, Italy.

Antonio Amoroso (A)

Immunogenetics and Transplant Biology Service, Azienda Ospedaliero-Universitaria Città della Salute e della Scienza, Torino, Italy.
Department of Medical Sciences, University of Turin, Torino, Italy.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH